Regulating vaccines: can health-economics tools be used profitably?
Dhanasiri
Sujith Kumar
SK
Puliyel
Jacob M
JM
D003362:Cost-Benefit Analysis; D017850:Economics, Pharmaceutical; D006801:Humans; D017589:Immunization Programs / Q000191:economics; D018570:Risk Assessment; D014612:Vaccines / Q000191:economics*
D014612:Vaccines